Gyrus Capital's Essential Pharma refinances, inks two deals
Essential Pharma, a UK pharmaceutical company backed by Gyrus Capital, has completed a refinancing providing capital to continue its organic and inorganic growth strategy.
More on Refinancing
Unquote Private Equity Podcast: The PE auction in times of exit scarcity
Rachel Lewis joins Harriet Matthews to discuss how auction process dynamics are changing against the current market backdrop
Alcentra takes keys to three PE-backed companies this year
Under Benefit Street Partners' ownership the alternative lender took over Lifetime, Optionis and Equiom
Searchlight invests in Celestyal Cruises
Searchlight is investing in the cruise operator via its Searchlight Opportunities Fund
Carlyle backs European strategies with ESG facility
Credit facility is linked to targets such as board diversity and greenhouse gas emissions monitoring
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater